Surrozen (SRZN) Accumulated Expenses (2020 - 2026)

Surrozen (SRZN) recorded quarterly Accumulated Expenses of $6.7 million in Q1 2026, down 14.7% quarter-over-quarter from $7.9 million in Q4 2025, and down 25.75% on a YoY basis from $9.1 million in Q1 2025.

Surrozen (SRZN) Accumulated Expenses (2020 - 2026) Analysis & Trends

Surrozen's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $6.7 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses fell 25.75% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (down 25.75% YoY), while the FY2025 annual figure was $7.9 million, up 52.74% from the prior year.
  • Accumulated Expenses was $6.7 million for Q1 2026 at Surrozen, down from $7.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $9.1 million in Q1 2025 to a low of $3.5 million in Q1 2024.
  • Historically, Accumulated Expenses has averaged $5.3 million across 5 years, with a median of $4.9 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 399.4% in 2022, then slumped 39.75% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $6.8 million in 2022, then plunged by 39.75% to $4.1 million in 2023, then rose by 25.55% to $5.2 million in 2024, then surged by 52.74% to $7.9 million in 2025, then declined by 14.7% to $6.7 million in 2026.
  • The last three Accumulated Expenses figures came in at $6.7 million (Q1 2026), $7.9 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Surrozen 225,877.86 -106.68 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.75 Mn
Dec 31, 2025 7.91 Mn
Sep 30, 2025 4.75 Mn
Jun 30, 2025 4.19 Mn
Mar 31, 2025 9.09 Mn
Dec 31, 2024 5.18 Mn
Sep 30, 2024 4.32 Mn
Jun 30, 2024 3.64 Mn
Mar 31, 2024 3.49 Mn
Dec 31, 2023 4.13 Mn
Sep 30, 2023 3.95 Mn
Jun 30, 2023 3.90 Mn
Mar 31, 2023 5.32 Mn
Dec 31, 2022 6.85 Mn
Sep 30, 2022 6.13 Mn
Jun 30, 2022 6.01 Mn
Mar 31, 2022 4.93 Mn
Dec 31, 2021 8.66 Mn
Sep 30, 2021 8.50 Mn
Jun 30, 2021 1.54 Mn